18 May 2013
Keywords: Pharma outlook, Nomura, India, Australia, Japan, China, Europe, Health reform
Article | 15 February 2011
Considering the outlook for the pharmaceutical industry, an analyst at Nomura says he is bullish on India with its patent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.